Cannabis Derived Drug Could Be a Game Changer for Children with Severe Epilepsy

Researchers say a new cannabis derived drug, which is expected to receive full approval from the FDA this week, will be a vital intervention for children with Dravet Syndrome and Lennox-Gastaut syndrome.